Stable Angina Management and Treatment
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Stable Angina, Coronary Artery Disease. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Poland
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Prospective REgistry of Stable Angina manaGEment and Treatment
Overview
The Prospective REgistry of Stable Angina manaGEment and Treatment (PRESAGE) is an observational study on an all-comer stable angina population hospitalised in a highly specialized cardiovascular centre with cardiac surgery facilities. The aim of the study is to assess the clinical characteristics, treatment modalities, early and long-term outcomes in this population.
Detailed description
The Prospective REgistry of Stable Angina manaGEment and Treatment (PRESAGE) is a single-center, observational study recruiting consecutive patients with stable angina, who were diagnosed and treated in the 3rd Chair and Department of Cardiology in the Silesian Centre for Heart Diseases in Zabrze, Poland. The Silesian Centre for Heart Diseases is a highly specialised cardiology centre with cardiac surgery facilities
The main objective of the PRESAGE Registry is to clarify the overall clinical characteristics of patients with stable angina, their demographics and clinical profile, current management, early and long-term outcomes, with regard to the administered treatment.
The diagnosis of stable angina was based on clinical characterization, coronary angiography, and the current guidelines of the European Society of Cardiology. Patients with vasospastic and/or microvascular angina were also included to the registry. Performance of coronary angiography is the criterion of the enrolment in the registry.
Patients with acute coronary syndromes are excluded from the analysis.
Data collection is patient-based (not event-based).
Complete patient demographics: medical history, complete hospitalization data (diagnostic and therapeutic) and in-hospital results are collected in an electronic form by the attending physician. The patients are under constant follow-up for all-cause mortality and major cardiac adverse events.
Primary outcome measures
- Number of participants with reported deaths from any cause [Time frame: From date of inclusion until the date of death from any cause, assessed up to 5 year]
Secondary outcome measures (3)
- Number of participants with reported myocardial infarction [Time frame: From date of inclusion until the date of first event, assessed up to 5 year]
- Number of participants with reported cerebrovascular insult [Time frame: From date of inclusion until the date of first event, assessed up to 5 year]
- Number of participants with reported acute coronary syndrome driven revascularisation [Time frame: From date of inclusion until the date of first event, assessed up to 5 year]
Eligibility criteria
Inclusion criteria
- symptom based diagnosis of stable angina
Exclusion criteria
- acute coronary syndrome on admission
- ≤ 18 years old
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Study design
- Observational model
- Cohort
Study locations
Poland · 1 center
- 3rd Chair and Department of Cardiology of Silesian Centre for Heart Diseases — Zabrze
Identifiers
NCT: NCT03781492 · PRESAGE Registry